Cubist Systematic Strategies’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
AVM
MM
Cubist Systematic Strategies's BEAM Position: Q2 2024 in Review
Cubist Systematic Strategies sold out of Beam Therapeutics (BEAM) in Q2 2024, closing a stake of 81,220 shares — an estimated $2.68M sold.
Cubist Systematic Strategies first reported a position in BEAM in Q2 2020 and held it in 13 quarters. The position peaked at $7.91M in Q2 2022. 214 funds tracked by Wall St. Rank hold BEAM as of Q2 2024.
- Cubist Systematic Strategies reported no remaining Beam Therapeutics position as of Q2 2024 after selling out during the quarter.
- Cubist Systematic Strategies sold 81,220 Beam Therapeutics shares in Q2 2024, an estimated $2.68M.
- Cubist Systematic Strategies first reported a position in Beam Therapeutics in Q2 2020 and held it in 13 quarters.
- Cubist Systematic Strategies's Beam Therapeutics position peaked at $7.91M in Q2 2022.
- 214 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2024.
Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.